Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

785 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
1-(Arylpiperazinylamidoalkyl)-pyrimidones: orally active inhibitors of lipoprotein-associated phospholipase A(2).
Bloomer JC, Boyd HF, Hickey DM, Ife RJ, Leach CA, Macphee CH, Milliner KJ, Pinto IL, Rawlings DA, Smith SA, Stansfield IG, Stanway SJ, Taylor MA, Theobald CJ, Whittaker CM. Bloomer JC, et al. Among authors: taylor ma. Bioorg Med Chem Lett. 2001 Jul 23;11(14):1925-9. doi: 10.1016/s0960-894x(01)00346-8. Bioorg Med Chem Lett. 2001. PMID: 11459662
The discovery of SB-435495. A potent, orally active inhibitor of lipoprotein-associated phospholipase A(2) for evaluation in man.
Blackie JA, Bloomer JC, Brown MJ, Cheng HY, Elliott RL, Hammond B, Hickey DM, Ife RJ, Leach CA, Lewis VA, Macphee CH, Milliner KJ, Moores KE, Pinto IL, Smith SA, Stansfield IG, Stanway SJ, Taylor MA, Theobald CJ, Whittaker CM. Blackie JA, et al. Among authors: taylor ma. Bioorg Med Chem Lett. 2002 Sep 16;12(18):2603-6. doi: 10.1016/s0960-894x(02)00473-0. Bioorg Med Chem Lett. 2002. PMID: 12182870
The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2.
Blackie JA, Bloomer JC, Brown MJ, Cheng HY, Hammond B, Hickey DM, Ife RJ, Leach CA, Lewis VA, Macphee CH, Milliner KJ, Moores KE, Pinto IL, Smith SA, Stansfield IG, Stanway SJ, Taylor MA, Theobald CJ. Blackie JA, et al. Among authors: taylor ma. Bioorg Med Chem Lett. 2003 Mar 24;13(6):1067-70. doi: 10.1016/s0960-894x(03)00058-1. Bioorg Med Chem Lett. 2003. PMID: 12643913
Content analysis of perceptions of combined pharmacobehavioral treatment for American Indian people with opioid use disorder.
Nelson LA, Collins SE, Shinagawa E, Park S, Rajeev V, McPhail G, Saplan S, Taylor EM, Aguilar-Bonnette AT, Mednansky S, Douthitt J, King RJ, Taylor MA, Kominsky TK, Green C, Saxon AJ, Clifasefi SL; CHaRRM-CN Community Advisory Board. Nelson LA, et al. Among authors: taylor ma. Psychol Addict Behav. 2025 Jan 9. doi: 10.1037/adb0001037. Online ahead of print. Psychol Addict Behav. 2025. PMID: 39786831
Health and Liver Diagnostic Markers Influencing Glycemia in Subjects with Prediabetes: Preview Study.
Ramos-Lopez O, Martinez-Urbistondo D, Navas-Carretero S, Zhu R, Huttunen-Lenz M, Stratton G, Handjieva-Darlenska T, Handjiev S, Sundvall JE, Silvestre MP, Jalo E, Pietiläinen KH, Adam TC, Westerterp-Plantenga M, Simpson E, MacDonald I, Taylor MA, Poppitt SD, Schlicht W, Brand-Miller J, Fogelholm M, Raben A, Martinez JA. Ramos-Lopez O, et al. Among authors: taylor ma. Diagnostics (Basel). 2024 Dec 23;14(24):2895. doi: 10.3390/diagnostics14242895. Diagnostics (Basel). 2024. PMID: 39767255 Free PMC article.
785 results